Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 3

Status

Completed 3Recruiting 2Unknown 1Terminated 1

Sponsor Class

OTHER 7NIH 2NETWORK 1

Study Type

Interventional 6Observational 1

Sponsor

Cancer Type

Endocrine 7Genitourinary 1

Conditions

Adrenocortical Carcinoma 7Adrenal Gland Neoplasms 1

Interventions

lutetium Lu 177 dotatate 36Everolimus 32pembrolizumab 24Temozolomide 21Magnetic Resonance Spectroscopy 21Nivolumab 18lenvatinib 17gallium Ga 68 dotatate 16cabozantinib 15Cisplatin 15lanreotide 143-Iodobenzylguanidine 14Capecitabine 13trametinib 12dabrafenib 12Bevacizumab 12Octreotide 11Surveys and Questionnaires 10Surgical Procedures, Operative 10Sunitinib 10Radiosurgery 10Positron Emission Tomography Computed Tomography 10Blood Specimen Collection 10Sorafenib 9Paclitaxel 9Ipilimumab 9Carboplatin 9surufatinib 8Etoposide 8Doxorubicin 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
OTHER × Mitotane × Endocrine × Clear all
NCT05634577 2025-06-19

A Phase II Study to Evaluate the Efficacy and Safety of Pembrolizumab in Combination With Mitotane in Patients With Advanced Adrenocortical Carcinoma

M.D. Anderson Cancer Center

Phase 2 Terminated
3 enrolled 7 charts
Endocrine

Adrenocortical Carcinoma

NCT06831175 2025-06-03

Phase II Study of PD-1 Inhibitor Combined With Apatinib and Mitotane in the Treatment of Advanced Adrenal Cortical Carcinoma

West China Hospital

Phase 2 Recruiting
28 enrolled
Endocrine

Adrenal Gland Neoplasms, Adrenocortical Carcinoma

NCT03723941 2024-08-01

ACACIA

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Phase 3 Completed
40 enrolled
Endocrine

Adrenocortical Carcinoma

NCT05913427 2024-08-01

PESETA

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Phase 2 Recruiting
80 enrolled
Endocrine

Adrenocortical Carcinoma

NCT05344027 2023-03-08

MitoS-FP

King's College Hospital NHS Trust

Completed
35 enrolled
Endocrine

Adrenocortical Carcinoma

NCT00777244 2017-05-08

ADIUVO

University of Turin, Italy

Phase 3 Unknown
200 enrolled
Endocrine

Adrenocortical Carcinoma

NCT00094497 2016-09-21

Trial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment (FIRM-ACT)

Collaborative Group for Adrenocortical Carcinoma Treatment

Phase 3 Completed
304 enrolled 12 charts
Endocrine

Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡